Open Access
| Issue |
BIO Web Conf.
Volume 237, 2026
2026 8th International Conference on Biotechnology and Biomedicine (ICBB 2026)
|
|
|---|---|---|
| Article Number | 01025 | |
| Number of page(s) | 6 | |
| Section | Molecular and Cellular Pathophysiology | |
| DOI | https://doi.org/10.1051/bioconf/202623701025 | |
| Published online | 10 June 2026 | |
- S. Ramón y Cajal, M. Sesé, C. Capdevila, T. Aasen, L. De Mattos-Arruda, S. J. Diaz-Cano, J. Hernández-Losa, and J. Castellví, “Clinical implications of intratumor heterogeneity: Challenges and opportunities,” J. Mol. Med., vol. 98, no. 2, pp. 161–177, 2020. [Google Scholar]
- I. Januskeviciene and V. Petrikaite, “Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations,” Life Sciences, vol. 239, Art. no. 117009, 2019. [Google Scholar]
- M. Raatz, S. Shah, G. Chitadze, M. Brüggemann, and A. Traulsen, “The impact of phenotypic heterogeneity of tumour cells on treatment and relapse dynamics,” PLoS Comput. Biol., vol. 17, no. 2, Art. no. e1008702, 2021. [Google Scholar]
- Z. Yu, T. G. Pestell, M. P. Lisanti, and R. Pestell, “Cancer stem cells,” Int. J. Biochem. Cell Biol., vol. 44, no. 12, pp. 2144–2151, 2012 [Google Scholar]
- K. Esfahani, L. Roudaia, N. A. Buhlaiga, S. V. Del Rincon, N. Papneja, and W. H. Miller, “A review of cancer immunotherapy: From the past, to the present, to the future,” Current Oncology, vol. 27, suppl. 2, pp. 87–97, 2020. [Google Scholar]
- W. Sukpol, T. Laomettachit, and A. Tangthanawatsakul, “A cancer sub-population competition model reveals optimal levels of immune response that minimize tumor size,” J. Comput. Biol., vol. 31, no. 11, pp. 1179–1194, 2023. [Google Scholar]
- K. Li, Z. Zhang, Y. Mei, M. Li, Q. Yang, Q. Wu, H. Yang, L. He, and S. Liu, “Targeting the innate immune system with nanoparticles for cancer immunotherapy,” J. Mater. Chem. B, vol. 10, no. 11, pp. 1709–1733, 2022. [Google Scholar]
- A. R. Freischel, M. Damaghi, J. J. Cunningham, A. Ibrahim-Hashim, R. J. Gillies, R. A. Gatenby, and J. S. Brown, “Frequency-dependent interactions determine outcome of competition between two breast cancer cell lines,” Scientific Reports, vol. 11, no. 1, pp. 1–18, 2021. [CrossRef] [PubMed] [Google Scholar]
- L. G. De Pillis, A. E. Radunskaya, and C. L. Wiseman, “A validated mathematical model of cell-mediated immune response to tumor growth,” Cancer Research, vol. 65, no. 17, pp. 7950–7958, 2005. [Google Scholar]
- M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proc. Natl. Acad. Sci. U.S.A., vol. 100, no. 7, pp. 3983–3988, 2003. [Google Scholar]
- L. G. De Pillis, W. Gu, and A. E. Radunskaya, “Mixed immunotherapy and chemotherapy of tumors: Modeling, applications and biological interpretations,” J. Theor. Biol., vol. 238, no. 4, pp. 841–862, 2006. [CrossRef] [Google Scholar]
- C. Enrico Bena, M. Del Giudice, A. Grob, T. Gueudré, M. Miotto, D. Gialama, M. Osella, E. Turco, F. Ceroni, A. De Martino, and C. Bosia, “Initial cell density encodes proliferative potential in cancer cell populations,” Scientific Reports, vol. 11, no. 1, Art. no. 6101, 2021. [Google Scholar]
- I. Kareva and F. Berezovskaya, “Cancer immunoediting: A process driven by metabolic competition as a predator–prey–shared resource type model,” J. Theor. Biol., vol. 380, pp. 463–472, 2015. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.